🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of acetaminophen, alleging the firms concealed safety concerns that the pain reliever created to children's neurological development.

The lawsuit comes four weeks after Donald Trump publicized an unproven link between using Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in offspring.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic approved for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he stated they "misled consumers by making money from pain and promoting medication regardless of the potential hazards."

The company says there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering millions to line their pockets," the attorney general, a Republican, said.

The manufacturer stated officially that it was "seriously troubled by the spread of false claims on the reliability of acetaminophen and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also said it had "consistently assessed the relevant science and there is insufficient valid information that indicates a proven link between consuming acetaminophen and autism."

Associations representing medical professionals and medical practitioners agree.

The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is a restricted selection for pregnant women to manage pain and fever, which can pose major wellness concerns if left untreated.

"In more than two decades of research on the utilization of acetaminophen in gestation, no reliable research has successfully concluded that the consumption of acetaminophen in any trimester of gestation leads to brain development issues in children," the group commented.

The lawsuit mentions current declarations from the former administration in claiming the medication is reportedly hazardous.

In recent weeks, Trump generated worry from medical authorities when he advised pregnant women to "fight like hell" not to consume acetaminophen when ill.

The US Food and Drug Administration then released a statement that physicians should contemplate reducing the usage of acetaminophen, while also stating that "a causal relationship" between the drug and autism spectrum disorder in minors has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had promised in April to initiate "extensive scientific investigation" that would determine the cause of autism in a limited time.

But authorities advised that identifying a unique factor of autism - thought by researchers to be the consequence of a complex mix of inherited and surrounding conditions - would be difficult.

Autism is a category of enduring cognitive variation and impairment that impacts how persons perceive and relate to the surroundings, and is identified using physician assessments.

In his lawsuit, Paxton - aligned with the former president who is running for federal office - claims Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the research" around paracetamol and autism spectrum disorder.

This legal action aims to force the firms "destroy any promotional materials" that claims Tylenol is reliable for pregnant women.

The Texas lawsuit parallels the grievances of a assembly of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the manufacturers of Tylenol in recently.

A federal judge rejected the case, stating studies from the parents' expert witnesses was lacking definitive proof.